Abstract Disclosures
1
842 jmd.amjpathol.org ■ The Journal of Molecular Diagnostics AMP Abstracts Disclosure of Financial Relationships and Resolution of Conflicts of Interest The Association for Molecular Pathology requires that readers of abstracts accepted for poster presentation at the Annual Meeting be informed of the authors’ academic and professional affiliations, as well as the existence of any relationships that may bias the presentation or which, if known, could give the perception of bias. Authors were asked to disclose potential conflicts of interest. The disclosures were reviewed by the AMP Program Committee prior to acceptance of the abstract. Relationships include, but are not limited to: 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) research grants; 3) employment (full or part-time); 4) ownership or partnership; 5) consulting fees or other remuneration; 6) nonremunerative positions of influence such as officer, board member, trustee, or public spokesperson; 7) receipt of royalties; 8) speaker’s bureau; 9) other. For full-time employees of industry or government, the affiliation listed in the abstract will constitute full disclosure. Program Committee Several of the organizers of this educational activity disclosed a relevant financial relationship that, in the context of their presentation could be perceived by some as a real or apparent conflict of interest. The disclosures have been reviewed and conflicts of interest resolved or managed. Organizers that disclosed no relevant financial relationship are also listed. x Franklin R. Cockerill, Mayo Clinic Chair, Department of Laboratory Medicine and Pathology CEO, Mayo Medical Laboratories Honorarium and royalties from Roche Diagnostics as an Advisory Board member (also spouse) Honorarium from NanoMR as an Advisory Board member Honorarium from Silicon Valley Bio as an Advisory Board member Spouse receives honorarium from Roche-Genentech, AstraZeneca, and Pfizer as an Advisor x Madhuri Hegde, Emory University, Associate Professor Honoraria from Illumina and Nimblegen as a speaker x Charles E. Hill, Emory University, Director, Molecular Diagnostics Consulting fee from Roche Molecular Diagnosticsas a Scientific Advisory Board member x David Hillyard, ARUP Laboratories, Medical Director Honoraria from Roche, Primera Dx, Thermo Fisheras an Advisory Board member Honorarium from Abbott Labs as a consultant and speaker x Michael A. Lewinski, Roche Molecular Systems Senior Director, Clinical Research, Microbiology Honorarium from Exact Sciences as a Lab Advisory Board Member x Marina N. Nikiforova, University of Pittsburgh Medical Center Director, Molecular Anatomic Pathology Laboratory, Associate Professor Honorarium from Novartis Diagnostics and CSI Laboratories as an Advisory Board Member x Daniel E. Sabath, University of Pittsburgh Medical Center Director, Molecular Anatomic Pathology Laboratory, Associate Professor Consulting fees from RareCyte, Inc. as a consultant x Ernst-Jan M. Speel, Maastricht University Medical Center Honorarium from Pfizer as a speaker and Advisory Board member Honorarium from Lilly as a speaker The remaining AMP 2013 Program Committee members have no relevant financial relationships to disclose: x Lara M. Brusca, Children’s Hospital Colorado, Molecular Lab Manager x Helen D. Fernandes, New Jersey Medical School, Rutgers University, Associate Professor x Jennifer L. Hunt, University of Arkansas for Medical Sciences, Chair of Pathology & Laboratory Medicine x Kimberly A. Lebel, Baystate Health, Supervisor x Megan S. Lim, University of Michigan, Professor and Director of Hematopathology x Rajyalakshmi Luthra, University of Texas MD Anderson Cancer Center, Professor x Ronald M. Przygodzki, Department of Veterans Affairs, Acting Director, Biomedical Laboratory, Associate Director, Genomic Medicine Program x Siby Sebastian, Duke University Health System, Associate Director, Clinical Molecular Diagnostics Laboratory x Antony E. Shrimpton, SUNY Upstate Medical University, Director Molecular Pathology Lab Authors of Abstracts A list of authors who indicated a relevant financial relationship is posted at the AMP 2013 Annual Meeting Abstracts webpage: http://www.2013amp.org/documents/Disclosure.Author.2013A.pdf . If an author is not listed, then s/he did not disclose a relationship.
Transcript of Abstract Disclosures
842 jmd.amjpathol.org ■ The Journal of Molecular Diagnostics
AMP Abstracts
Disclosure of Financial Relationships and Resolution of Conflicts of Interest The Association for Molecular Pathology requires that readers of abstracts accepted for poster presentation at the Annual Meeting be informed of the authors’ academic and professional affiliations, as well as the existence of any relationships that may bias the presentation or which, if known, could give the perception of bias. Authors were asked to disclose potential conflicts of interest. The disclosures were reviewed by the AMP Program Committee prior to acceptance of the abstract. Relationships include, but are not limited to: 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) research grants; 3) employment (full or part-time); 4) ownership or partnership; 5) consulting fees or other remuneration; 6) nonremunerative positions of influence such as officer, board member, trustee, or public spokesperson; 7) receipt of royalties; 8) speaker’s bureau; 9) other. For full-time employees of industry or government, the affiliation listed in the abstract will constitute full disclosure.
Program Committee Several of the organizers of this educational activity disclosed a relevant financial relationship that, in the context of their presentation could be perceived by some as a real or apparent conflict of interest. The disclosures have been reviewed and conflicts of interest resolved or managed. Organizers that disclosed no relevant financial relationship are also listed.
Franklin R. Cockerill, Mayo Clinic Chair, Department of Laboratory Medicine and Pathology CEO, Mayo Medical Laboratories Honorarium and royalties from Roche Diagnostics as an Advisory Board member (also spouse) Honorarium from NanoMR as an Advisory Board member Honorarium from Silicon Valley Bio as an Advisory Board member Spouse receives honorarium from Roche-Genentech, AstraZeneca, and Pfizer as an Advisor
Madhuri Hegde, Emory University, Associate Professor Honoraria from Illumina and Nimblegen as a speaker
Charles E. Hill, Emory University, Director, Molecular Diagnostics Consulting fee from Roche Molecular Diagnosticsas a Scientific Advisory Board member
David Hillyard, ARUP Laboratories, Medical Director Honoraria from Roche, Primera Dx, Thermo Fisheras an Advisory Board member Honorarium from Abbott Labs as a consultant and speaker
Michael A. Lewinski, Roche Molecular Systems Senior Director, Clinical Research, Microbiology Honorarium from Exact Sciences as a Lab Advisory Board Member
Marina N. Nikiforova, University of Pittsburgh Medical Center Director, Molecular Anatomic Pathology Laboratory, Associate Professor Honorarium from Novartis Diagnostics and CSI Laboratories as an Advisory Board Member
Daniel E. Sabath, University of Pittsburgh Medical Center Director, Molecular Anatomic Pathology Laboratory, Associate Professor Consulting fees from RareCyte, Inc. as a consultant
Ernst-Jan M. Speel, Maastricht University Medical Center Honorarium from Pfizer as a speaker and Advisory Board member
Honorarium from Lilly as a speaker
The remaining AMP 2013 Program Committee members have no relevant financial relationships to disclose: Lara M. Brusca, Children’s Hospital Colorado, Molecular Lab Manager Helen D. Fernandes, New Jersey Medical School, Rutgers University, Associate Professor Jennifer L. Hunt, University of Arkansas for Medical Sciences, Chair of Pathology & Laboratory Medicine Kimberly A. Lebel, Baystate Health, Supervisor Megan S. Lim, University of Michigan, Professor and Director of Hematopathology Rajyalakshmi Luthra, University of Texas MD Anderson Cancer Center, Professor Ronald M. Przygodzki, Department of Veterans Affairs, Acting Director, Biomedical Laboratory, Associate
Director, Genomic Medicine Program Siby Sebastian, Duke University Health System, Associate Director, Clinical Molecular Diagnostics Laboratory Antony E. Shrimpton, SUNY Upstate Medical University, Director Molecular Pathology Lab
Authors of Abstracts A list of authors who indicated a relevant financial relationship is posted at the AMP 2013 Annual Meeting Abstracts webpage: http://www.2013amp.org/documents/Disclosure.Author.2013A.pdf. If an author is not listed, then s/he did not disclose a relationship.
